评估角膜共聚焦显微镜及其他小纤维检测在糖尿病多发性神经病中的作用
本研究为队列研究,纳入214例至少可能糖尿病多发性神经病(DPN)患者、63例无DPN患者和97例无糖尿病对照,比较角膜共聚焦显微镜(CCM)、表皮内神经纤维密度(IENFD)、冷检测阈值(CDT)和热检测阈值(WDT)诊断DPN的效能。DPN患者CCM各项指标、IENFD、CDT和WDT均低于无DPN患者,但CCM诊断敏感性最低(CNFL敏感性14.4%,特异性95.7%),IENFD敏感性最高(51.1%),CCM与其他小纤维检测无相关性,提示CCM在近期诊断的2型糖尿病中检测DPN敏感性低。
要点
- DPN患者CCM指标(CNFL、神经纤维密度、分支密度)、IENFD、CDT和WDT均低于无DPN患者。
- CCM诊断敏感性最低,CNFL敏感性14.4%、特异性95.7%;IENFD敏感性最高为51.1%、特异性90%。
- CCM指标与IENFD、CDT/WDT及神经病变严重程度无相关性。
核心结论
- 与其他小纤维检测相比,CCM在诊断DPN中敏感性最低,提示CCM不是检测近期诊断的2型糖尿病中DPN的敏感方法。
研究设计与样本
- 队列研究,纳入214例至少可能DPN患者、63例无DPN患者和97例无糖尿病对照,均接受详细神经科检查、电生理、IENFD定量、CCM和定量感觉测试。
- DPN定义依据多伦多糖尿病神经病变标准(不依赖IENFD和温度阈值)。
主要发现
- DPN患者CNFL、神经纤维密度、分支密度、IENFD、CDT和WDT均低于无DPN患者(p≤0.001、<0.001、0.002、p<0.001、p=0.003和<0.005)。
- 无糖尿病对照与无DPN的糖尿病患者之间上述指标无差异。
- 3项CCM指标诊断敏感性均很低,CNFL最高为14.4%(95%CI 9.8-18.4),特异性95.7%(95%CI 88.0-99.1)。
- 异常CDT和/或WDT的敏感性为30.5%(95%CI 24.4-37.0),特异性84.9%(95%CI 74.6-92.2);异常IENFD敏感性最高为51.1%(95%CI 43.7-58.5),特异性90%(95%CI 79.5-96.2)。
- 在DPN患者组中,CCM指标与IENFD、CDT/WDT或神经病变严重程度无相关性。
关键数值与推荐
- CCM指标CNFL诊断敏感性14.4%(95%CI 9.8-18.4),特异性95.7%(95%CI 88.0-99.1)。
- 异常CDT和/或WDT敏感性30.5%(95%CI 24.4-37.0),特异性84.9%(95%CI 74.6-92.2)。
- 异常IENFD敏感性51.1%(95%CI 43.7-58.5),特异性90%(95%CI 79.5-96.2)。
临床怎么用
- 本研究提供III级证据表明CCM指标有助于检测近期诊断的2型糖尿病中的DPN,但与其他小纤维检测相比敏感性低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Damage to small nerve fibers is common in diabetic polyneuropathy (DPN), and the diagnosis of DPN relies on subjective symptoms and signs in a combination with objective confirmatory tests, typically electrophysiology or intraepidermal nerve fiber density (IENFD) from skin biopsy. Corneal confocal microscopy (CCM) has been introduced as a tool to detect DPN. However, it is unclear if CCM can reliably be used to diagnose DPN and how the technique compares with other commonly used measures of small fiber damage, such as IENFD, cold detection threshold (CDT), and warm detection threshold (WDT). Therefore, we assessed and compared the use of CCM, IENFD, CDT, and WDT in the diagnosis of DPN in patients with type 2 diabetes. METHODS: In this cohort study, the participants underwent detailed neurologic examination, electrophysiology, quantification of IENFD, CCM, and quantitative sensory testing. Definition of DPN was made in accordance with the Toronto criteria for diabetic neuropathy (without relying on IENFD and thermal thresholds). RESULTS: A total of 214 patients with at least probable DPN, 63 patients without DPN, and 97 controls without diabetes were included. Patients with DPN had lower CCM measures (corneal nerve fiber length [CNFL], nerve fiber density, and branch density), IENFD, CDT, and WDT compared with patients without DPN (p ≤ 0.001, <0.001, 0.002, p < 0.001, p = 0.003, and <0.005, respectively), whereas there was no difference between controls and patients with diabetes without DPN. All 3 CCM measures showed a very low diagnostic sensitivity with CNFL showing the highest (14.4% [95% CI 9.8-18.4]) and a specificity of 95.7% (88.0-99.1). In comparison, the sensitivity of abnormal CDT and/or WDT was 30.5% (24.4-37.0) with a specificity of 84.9% (74.6-92.2). The sensitivity of abnormal IENFD was highest among all measures with a value of 51.1% (43.7-58.5) and a specificity of 90% (79.5-96.2). CCM measures did not correlate with IENFD, CDT/WDT, or neuropathy severity in the group of patients with DPN. DISCUSSION: CCM measures showed the lowest sensitivity compared with other small fiber measures in the diagnosis of DPN. This indicates that CCM is not a sensitive method to detect DPN in recently diagnosed type 2 diabetes. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that CCM measures aid in the detection of DPN in recently diagnosed type 2 diabetics but with a low sensitivity when compared with other small fiber measures.
引用
- Gylfadottir SS, Itani M, Kristensen AG, et al. Assessing Corneal Confocal Microscopy and Other Small Fiber Measures in Diabetic Polyneuropathy. Neurology. 2023. PMID: 36750383. doi:10.1212/WNL.0000000000206902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。